mimetic

(redirected from Mimetics)
Also found in: Dictionary, Thesaurus, Medical.

mimetic

Biology of or exhibiting mimicry

mimetic

[mə′med·ik]
(crystallography)
Pertaining to a crystal that is twinned or malformed but whose crystal symmetry appears to be of a higher grade than it actually is.
(petrology)
Of a tectonite, having a deformation fabric, formed by mimetic crystallization, that reflects and is influenced by preexisting anisotropic structure.
(zoology)
Pertaining to or exhibiting mimicry.
References in periodicals archive ?
These statements include those related to clinical trials of LGD 4665, other TPO related drugs or mimetics, market size and potential, LGD 4665 profile, efficacy, potency, selectivity, competitiveness and potential, and number of patients.
In what will follow below I will first point out some of the problems that Kita's analysis faces regarding adverbial mimetics and will argue that at least some of the arguments that he advances to motivate the dichotomy of the two dimensions are not as convincing as he intends.
Fat mimetics The third category of fat substitutes is actually not a fat at all.
By utilizing the expertise of the supplier in understanding the functionalities of different specialty food starches and recognizing that every food formulated and processed differs in reaction with any fat replacer utilized, this new line of fat mimetics is claimed to provide advantages over alternative substitutes available.
This application is part of an expanding international patent portfolio for TetraLogic with Japan being the ninth country to acknowledge the patentability of the company's Smac mimetics.
According to the company, the US Patent 8,580,746, entitled 'Amide Linkage Cyclic Natriuretic Peptide Constructs,' has composition of matter claims to a novel series of mimetics of atrial natriuretic peptide.
I agree with Tsujimura that it is not fruitful to equate the compatibility requirements imposed by mimetics and selectional restrictions in the classic sense.
Its dismutase mimetics have demonstrated initial safety in human studies and potent pre-clinical activity, both in attacking tumors and in protecting normal tissue from diseases such as fibrosis and damage such as radiation.
8 January 2010 - TetraLogic Pharmaceuticals said today it has completed dosing of the first cohort in a Phase I trial of its selective SMAC mimetic, TL32711, in patients with refractory solid tumours or lymphoma.
TetraLogic Pharmaceuticals, a biopharmaceutical company developing novel small molecule Smac mimetic drugs to treat cancer, today announced the poster presentation of preclinical data on its Smac mimetic drug candidate birinapant at the 54th ASH Annual Meeting and Exposition in Atlanta, Georgia.
TetraLogic Pharmaceuticals, a biopharmaceutical company developing novel small molecule Smac mimetic drugs to treat cancer, today announced that new preclinical data on its Smac mimetic drug candidate birinapant (formerly TL32711) were presented this week at the 103rd American Association for Cancer Research (AACR) Annual Meeting in Chicago.
We believe our small molecule defensin- mimetic compounds represent a novel approach to developing new agents to treat these painful infections which sometimes can be life-threatening, with the important potential advantage of limited opportunity for the development of resistance.